Peer Review reports
From: Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival
| Original Submission | ||
|---|---|---|
| 7 May 2021 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 20 May 2021 | Reviewed | Reviewer Report - Manuela Caroli |
| 2 Jun 2021 | Reviewed | Reviewer Report |
| 2 Sep 2021 | Author responded | Author comments - Risheng Liang |
| Resubmission - Version 4 | ||
| 2 Sep 2021 | Submitted | Manuscript version 4 |
| 5 Sep 2021 | Reviewed | Reviewer Report - Manuela Caroli |
| 7 Sep 2021 | Reviewed | Reviewer Report |
| 9 Oct 2021 | Author responded | Author comments - Risheng Liang |
| Resubmission - Version 5 | ||
| 9 Oct 2021 | Submitted | Manuscript version 5 |
| 11 Oct 2021 | Author responded | Author comments - Risheng Liang |
| Resubmission - Version 6 | ||
| 11 Oct 2021 | Submitted | Manuscript version 6 |
| 17 Oct 2021 | Reviewed | Reviewer Report - Manuela Caroli |
| Resubmission - Version 7 | ||
| Submitted | Manuscript version 7 | |
| Publishing | ||
| 22 Oct 2021 | Editorially accepted | |
| 2 Nov 2021 | Article published | 10.1186/s12883-021-02461-9 |
You can find further information about peer review here.